4//SEC Filing
JACOBS JOEY A 4
Accession 0001209191-19-033695
CIK 0001087294other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:12 PM ET
Size
18.7 KB
Accession
0001209191-19-033695
Insider Transaction Report
Form 4
JACOBS JOEY A
Director
Transactions
- Purchase
Common Stock
2019-05-10$5.92/sh+931$5,512→ 82,651 total - Purchase
Common Stock
2019-05-17$6.20/sh+794$4,923→ 85,015 total - Purchase
Common Stock
2019-05-21$6.49/sh+850$5,517→ 86,715 total - Purchase
Common Stock
2019-05-23$6.44/sh+850$5,474→ 88,415 total - Purchase
Common Stock
2019-05-13$5.67/sh+526$2,982→ 83,177 total - Purchase
Common Stock
2019-05-20$6.89/sh+850$5,857→ 85,865 total - Purchase
Common Stock
2019-05-14$5.48/sh+66$362→ 83,243 total - Purchase
Common Stock
2019-05-15$6.00/sh+677$4,062→ 83,920 total - Purchase
Common Stock
2019-05-16$5.99/sh+301$1,803→ 84,221 total - Purchase
Common Stock
2019-05-22$6.49/sh+850$5,517→ 87,565 total
Footnotes (1)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001243878
Filing Metadata
- Form type
- 4
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 5:12 PM ET
- Size
- 18.7 KB